|
|
 |
|
Viewing report
|
|
|
|
Migraine - Pipeline Assessment and Market Forecasts to 2016
GlobalData , July 2010, Pages: 47
Migraine - Pipeline Assessment and Market Forecasts to 2016
Summary
GlobalData, the industry analysis specialist’s new report, “Migraine - Pipeline Assessment and Market Forecasts to 2016” is an essential source of information and analysis on the global migraine market. The report identifies the key trends shaping and driving the global migraine market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global migraine sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Our team of industry experts.
Scope
The report provides information on the key driver and challenges of the global migraine market. Its scope includes:
- Annualized global migraine market revenues data from 2001 to 2009, forecast forward for seven years to 2016.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Key classes of mechanism of action include 5-HT1D agonist, 5-HT1 agonist, AMPA/kainate receptor antagonist, Neuro transmitter system receptor, bacterial Neurotoxin (muscle relaxant), 5-HT targetor, calcitonin gene related peptide (CGRP) targetors, GABA transaminase inhibitors, nitric oxide inhibitors, prostaglandin synthesis inhibitor, opioid receptor agonist, antiemetic and gastroprokinetic agents, anti-inflammatory and immunosuppressant, and cyclooxygenase-2 (COX-2) inhibitors.
- Analysis of the current and future market competition in the global migraine market. Key market players covered are GlaxoSmithKline, Eli Lilly and Company, Merck & Co., Inc., Pozen, Inc., Eisai Co., Ltd., Johnson & Johnson, Inc., NuPathe Inc., and Abbott Laboratories.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the future market associated with migraine therapeutics.
Reasons to buy
The report will enhance your decision making capability in a rapid and time sensitive manner. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global migraine market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global migraine market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain the competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global migraine market landscape? - Identify, understand and capitalize.
Customers who bought this item also bought
Anti-Migraine Drugs - Global Strategic Business Report
The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights
Outlook for the Migraine Market With Novel Approaches Limited, Triptans Dominate
Migraine Therapeutics Market in the US: Market Forecast, Patient Flow, Competitive Landscape, and Pipeline Analysis
Anticonvulsants Market to 2016 - Cost Advantage and Dosage Convenience Provided by Generic Anticonvulsants Will Limit Commercial Opportunities for Novel Therapies
Global Migraine Therapeutics Market: Market Forecast, Patient Flow, Competitive Landscape, and Pipeline Analysis
Intranasal Drug Delivery - Global Strategic Business Report
Diabetes Market to 2016 - Biguanides and Insulin Analogs will be the Largest Selling Anti-Diabetic Drugs
Human Vaccines - Global Strategic Business Report
Migraine Therapeutics Market in Europe: Market Forecast, Patient Flow, Competitive Landscape, and Pipeline Analysis
|
|
|
|
